Analysts have been eager to weigh in on the Healthcare sector with new ratings on Cooper Co (COO) and UnitedHealth (UNH).
Cooper Co (COO)
Oppenheimer analyst Steven Lichtman maintained a Hold rating on Cooper Co on December 4 and set a price target of $357.00. The company’s shares closed last Monday at $359.96, close to its 52-week high of $371.59.
According to TipRanks.com, Lichtman is a 4-star analyst with an average return of 8.0% and a 55.1% success rate. Lichtman covers the Healthcare sector, focusing on stocks such as Zimmer Biomet Holdings, Merit Medical Systems, and Integra Lifesciences.
Currently, the analyst consensus on Cooper Co is a Moderate Buy with an average price target of $367.33, implying a 1.8% upside from current levels. In a report issued on December 4, Citigroup also maintained a Hold rating on the stock with a $355.00 price target.
See today’s analyst top recommended stocks >>
UnitedHealth (UNH)
In a report issued on December 4, Michael Wiederhorn from Oppenheimer maintained a Buy rating on UnitedHealth. The company’s shares closed last Monday at $345.95, close to its 52-week high of $367.95.
According to TipRanks.com, Wiederhorn is a top 100 analyst with an average return of 21.8% and a 75.2% success rate. Wiederhorn covers the Healthcare sector, focusing on stocks such as Community Health, The Ensign Group, and Addus Homecare.
UnitedHealth has an analyst consensus of Strong Buy, with a price target consensus of $386.58, representing a 12.6% upside. In a report issued on December 1, Merrill Lynch also maintained a Buy rating on the stock with a $400.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on UNH:
